<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7607088</journal-id>
<journal-id journal-id-type="pubmed-jr-id">673</journal-id>
<journal-id journal-id-type="nlm-ta">Annu Rev Pharmacol Toxicol</journal-id>
<journal-id journal-id-type="iso-abbrev">Annu. Rev. Pharmacol. Toxicol.</journal-id>
<journal-title-group>
<journal-title>Annual review of pharmacology and toxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0362-1642</issn>
<issn pub-type="epub">1545-4304</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28968186</article-id>
<article-id pub-id-type="pmc">6076890</article-id>
<article-id pub-id-type="doi">10.1146/annurev-pharmtox-010617-052645</article-id>
<article-id pub-id-type="manuscript">NIHMS941739</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Zheng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoo</surname>
<given-names>Seung-Hee</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takahashi</surname>
<given-names>Joseph S.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA; <email>zheng.chen.l@uth.tmc.edu</email></aff>
<aff id="A2"><label>2</label>Department of Neuroscience and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA</aff>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>06</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>58</volume>
<fpage>231</fpage>
<lpage>252</lpage>
<!--elocation-id from pubmed: 10.1146/annurev-pharmtox-010617-052645-->
<abstract id="ABS1">
<p id="P1">Circadian timekeeping systems drive oscillatory gene expression to regulate essential cellular and physiological processes. When the systems are perturbed, pathological consequences ensue and disease risks rise. A growing number of small-molecule modulators have been reported to target circadian systems. Such small molecules, identified via high-throughput screening or derivatized from known scaffolds, have shown promise as drug candidates to improve biological timing and physiological outputs in disease models. In this review, we first briefly describe the circadian system, including the core oscillator and the cellular networks. Research progress on clock-modulating small molecules is presented, focusing on development strategies and biological efficacies. We highlight the therapeutic potential of small molecules in clock-related pathologies, including jet lag and shiftwork; various chronic diseases, particularly metabolic disease; and aging. Emerging opportunities to identify and exploit clock modulators as novel therapeutic agents are discussed.</p>
</abstract>
<kwd-group>
<kwd>circadian clock</kwd>
<kwd>high-throughput screen</kwd>
<kwd>chemical derivatization</kwd>
<kwd>chronotherapy</kwd>
<kwd>clock-related diseases</kwd>
<kwd>aging</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>